These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 6254639

  • 1. Phase I study of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466) in adults with solid tumors.
    Stewart DJ, Benjamin RS, Leavens M, Valdivieso M, Burgess MA, Bodey GP.
    Cancer Res; 1980 Oct; 40(10):3750-4. PubMed ID: 6254639
    [No Abstract] [Full Text] [Related]

  • 2. Phase I trial and clinical pharmacology of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea.
    Woolley PV, Luc PV, Rahman A, Korsmeyer SJ, Smith FP, Schein PS.
    Cancer Res; 1981 Oct; 41(10):3896-900. PubMed ID: 7284999
    [Abstract] [Full Text] [Related]

  • 3. Phase I trial of PCNU.
    Kalman LA, Gralla RJ, Casper ES, Kris MG, Gordon C, Woodcock TM.
    Cancer Treat Rep; 1983 Nov; 67(11):1027-9. PubMed ID: 6315229
    [Abstract] [Full Text] [Related]

  • 4. 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.
    Wilson CB, Boldrey EB, Enot KJ.
    Cancer Chemother Rep; 1970 Aug; 54(4):273-81. PubMed ID: 4334089
    [No Abstract] [Full Text] [Related]

  • 5. Preliminary clinical trial of 1-(2-chlorethyl)-3-(4-methylcyclohexyl)-1 nitrosourea (NSC-95411) (MeCCNU) in human neoplasms.
    Gailani S, Kutcher J.
    J Med; 1973 Aug; 4(4):209-18. PubMed ID: 4520348
    [No Abstract] [Full Text] [Related]

  • 6. Phase I trial of PCNU administered by 5-day courses.
    Earhart RH, Koeller JM, Davis HL.
    Cancer Treat Rep; 1981 Aug; 65(9-10):835-40. PubMed ID: 7273016
    [Abstract] [Full Text] [Related]

  • 7. Comparative pharmacokinetics of 1-(2-chloroethyl)-3-(2,6-dioxo-1-piperidyl)-1-nitrosourea in rats and patients and extrapolation to clinical trials.
    Levin VA, Liu J, Weinkam RJ.
    Cancer Res; 1981 Sep; 41(9 Pt 1):3475-7. PubMed ID: 7020928
    [Abstract] [Full Text] [Related]

  • 8. [Phase I study of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea (TA-077). Phase I Study Group].
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2425-33. PubMed ID: 3729497
    [Abstract] [Full Text] [Related]

  • 9. Phase I study of 3-deazauridine in the treatment of adults with solid tumors.
    Stewart DJ, McCredie KD, Barlogie B, Valdivieso M, Benjamin RS, Burgess MA, Bodey GP.
    Cancer Treat Rep; 1980 Jul; 64(12):1295-9. PubMed ID: 7471119
    [Abstract] [Full Text] [Related]

  • 10. [Phase I study on oral administration of methyl-6-[[[(2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
    Kanamaru A, Nagai K, Fujita S, Masaoka T, Takubo T, Kitani T, Taniguchi N, Horiuchi A, Tsubaki K, Kawagoe H, Hirata M, Yonezawa T, Tsubakio T, Yasunaga K, Okamoto Y, Fujitake H, Ohkubo A.
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1831-7. PubMed ID: 6882006
    [Abstract] [Full Text] [Related]

  • 11. BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.
    Walker MD, Hurwitz BS.
    Cancer Chemother Rep; 1970 Aug; 54(4):263-71. PubMed ID: 4946011
    [No Abstract] [Full Text] [Related]

  • 12. 1-2(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU, NSC-79037): a comparison of drug administration at four-week and six-week intervals.
    Broder LE, Hansen HH.
    Eur J Cancer (1965); 1973 Feb; 9(2):147-52. PubMed ID: 4717488
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical significance of mustoforan in management of malignant glioma].
    Kobiakov GL.
    Vopr Onkol; 2007 Feb; 53(6):724-9. PubMed ID: 18416147
    [No Abstract] [Full Text] [Related]

  • 14. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in patients with metastatic colorectal cancer.
    Bedikian AY, Stroehlein JR, Karlin DA, Bennetts RW, Stewart DJ, Bodey GP.
    Am J Clin Oncol; 1983 Feb; 6(1):49-52. PubMed ID: 6837507
    [Abstract] [Full Text] [Related]

  • 15. Phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in small cell cancer of the lung.
    Chapman RA, Natale RB, Young CW, Wittes RE.
    Am J Clin Oncol; 1984 Oct; 7(5):413-4. PubMed ID: 6095639
    [Abstract] [Full Text] [Related]

  • 16. A comparative study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and imidazole carboxamide (NSC 45388) with vincristine (NSC 67574) in the palliation of disseminated malignant melanoma.
    Ahmann DL, Hahn RG, Bisel HF.
    Cancer Res; 1972 Nov; 32(11):2432-4. PubMed ID: 5082592
    [No Abstract] [Full Text] [Related]

  • 17. [Anti-tumor activity of ACNU against malignant glioma--a clinical application of in vitro sensitivity test of chemotherapeutic agent].
    Shibuya N, Yoshida J, Kobayashi T, Kageyama N.
    No Shinkei Geka; 1983 Apr; 11(4):361-7. PubMed ID: 6306497
    [Abstract] [Full Text] [Related]

  • 18. Phase I clinical study of the new amino acid-linked nitrosourea, S 10036, administered on a weekly schedule.
    Khayat D, Lokiec F, Bizzari JP, Weil M, Meeus L, Sellami M, Rouesse J, Banzet P, Jacquillat C.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6782-5. PubMed ID: 3677107
    [Abstract] [Full Text] [Related]

  • 19. A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors.
    Feun LG, Stewart DJ, Leavens ME, Burgess MA, Savaraj N, Benjamin RS, Bodey GP.
    J Neurooncol; 1983 Dec 15; 1(1):45-8. PubMed ID: 6678305
    [Abstract] [Full Text] [Related]

  • 20. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-(piperidyl)-1 nitrosourea (PCNU)(NSC-95466) in patients with advanced carcinoma of the lung.
    Ratanatharathorn V, Samson MK, Haas CD, Cummings GD, O'Connor EJ, Baker LH.
    Am J Clin Oncol; 1983 Feb 15; 6(1):99-102. PubMed ID: 6837509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.